Bedrijfsoverzicht
Corteva, Inc. is a leading entity within the agricultural sector, deriving its revenue from the development and supply of advanced germplasm, traits, and crop protection solutions designed to optimize farm yields and enhance resilience against weather conditions and diseases. The company operates within the Basic Materials sector, specifically categorized under the Agricultural Inputs industry, positioning it as a critical supplier of essential inputs for the global food production chain. Its current market capitalization stands at $56.38B, supported by an annual revenue of $17.40B and a substantial workforce of 21,500 employees. These valuation and revenue figures indicate that Corteva commands a significant market presence, reflecting its established role in providing specialized seed technologies and crop protection products that are integral to modern farming operations.
Financiële gezondheid
The company reported a revenue of $17.40B over the trailing twelve months, generating a net income of $1.19B and an EBITDA of $3.80B, which highlights a distinct gap between total revenue and net profit that underscores a specific cost structure involving substantial operating expenses. The organization generated $2.93B in free cash flow, a metric that signals robust financial flexibility allowing for potential capital allocation strategies such as debt repayment or share repurchases without compromising operational liquidity. Profitability metrics reveal a gross margin of 47.3%, an operating margin of 5.6%, and a profit margin of 6.3%, indicating that while the company maintains healthy gross pricing power, significant costs related to research, development, and distribution erode the final bottom-line profitability. On the balance sheet side, Corteva holds $4.53B in cash against $3.00B in debt, resulting in a debt-to-equity ratio of 12.28, which suggests a capital structure that is moderately leveraged given the high equity denominator relative to debt obligations. Short-term liquidity is supported by a current ratio of 1.43, indicating that the company possesses sufficient current assets to cover its current liabilities with a comfortable buffer. Return on equity stands at 5.0% while return on assets is 3.9%, revealing that management's effectiveness in generating returns on shareholder capital and the total asset base is moderate compared to high-growth technology sectors.
Waarderingsbeoordeling
Valuation multiples show a trailing P/E ratio of 47.90 compared to a forward P/E of 20.70, implying that the market currently prices in significantly higher future earnings growth expectations that would bring the valuation multiple down to a more moderate level over the next year. The price-to-book ratio is recorded at 2.33, suggesting that the market values the company at a premium of roughly 133% above its tangible book value, likely reflecting the intangible value of its proprietary seed traits and intellectual property. Alternative valuation metrics include a price-to-sales ratio of 3.24 and an EV/EBITDA of 14.50, which provide context that the company is valued heavily on its sales scale and cash-generating ability relative to its earnings before interest, taxes, depreciation, and amortization. In terms of trading range, the stock has seen a 52-week high of $85.63 and a 52-week low of $58.58, meaning the current share price sits somewhere within this band, reflecting recent market volatility. The beta coefficient is 0.68, indicating that the stock exhibits lower price volatility than the broader market, moving less aggressively during periods of general market upturns or downturns.
Growth & Income
Revenue growth for the year-over-year period is recorded at -1.7%, while earnings growth data is unavailable (N/A), creating a scenario where earnings performance is not directly correlated with the recent decline in top-line sales. For dividend payers like Corteva, the dividend yield is 0.9% with a payout ratio of 40.0%, a level that suggests the dividend is sustainable as it consumes less than half of the generated earnings per share. The combination of negative revenue growth and a moderate payout ratio indicates a phase where the company may be prioritizing operational efficiency and cost management over aggressive expansion or dividend increases. Overall, the growth and income profile presents a mature asset with limited recent top-line expansion but a consistent commitment to returning capital to shareholders through a stable dividend program.